Harlan Waksal, Executive Chair at Lyra Therapeutics, Inc. (LYRA), bought 25,000 shares at $2.96 ($74K) on 2023-11-10, disclosed to the SEC on 2023-11-13.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| KDMN | BUY | 2020-03-11 | $50K | — | Filing → |
| KDMN | BUY | 2017-08-10 | $11K | — | Filing → |
| KDMN | BUY | 2017-08-08 | $9K | — | Filing → |